All In Biotech

Drug Trial Radar · NCT02921022

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Pilot Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

110

Planned (sponsor's estimate)

Start

Oct 2016

Primary completion

Oct 2027

Study completion Oct 2027

Sponsor

Lead sponsor
Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Halozyme Therapeutics; Miami Cancer Institute
First posted
Sep 30, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test any good and bad effects of the study drug called PEGPH20. PEGPH20 alone is considered investigational. The Food and Drug Administration (FDA) has not approved the marketing or sale of PEGPH20, but have authorized its use in research studies with humans. PEGPH20 could shrink the cancer but it also can cause side effects. PEGPH20 is an enzyme that breaks down a specific tissue component called hyaluronan produced by some tumors. Pancreatic tumors often have a large amount of hyaluronan. The removal of hyaluronan from tumors may decrease tumor growth.

Conditions

  • Pancreatic Cancer
  • Advanced Pancreatic Ductal Adenocarcinoma

Interventions

  • GemcitabineDrug

  • Nab-paclitaxelDrug

  • PEGPH20Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. rate of symptomatic TE eventsTime frame: 1 year

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Hartford Healthcare Cancer Institute @ Hartford Hospital

    Hartford, Connecticut

  • Miami Cancer Institute

    Miami, Florida

  • Memorial Sloan Kettering Basking Ridge

    Basking Ridge, New Jersey

  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey

  • Memorial Sloan Kettering Bergen

    Montvale, New Jersey

  • Memorial Sloan Kettering Commack

    Commack, New York

  • Memorial Sloan Kettering Westchester

    Harrison, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Memorial Sloan Kettering Nassau

    Uniondale, New York

  • Lehigh Valley Health Network

    Allentown, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.